Quick Answer
NovoCure Ltd reported Shares Outstanding of 112.49 million shares for fiscal year 2025.
NovoCure Ltd Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 112.49M | +3.7% |
| 2024 | 108.52M | +1.3% |
| 2023 | 107.08M | +1.9% |
| 2022 | 105.05M | +1.0% |
| 2021 | 103.97M | +1.6% |
| 2020 | 102.33M | +2.8% |
| 2019 | 99.53M | +6.7% |
| 2018 | 93.25M | +4.2% |
| 2017 | 89.48M | +2.8% |
| 2016 | 87.07M | +3.9% |
| 2015 | 83.78M | +523.8% |
| 2014 | 13.43M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 111.98M | +3.6% | +0.2% |
| June 30, 2025 | 111.80M | +3.5% | +0.3% |
| March 31, 2025 | 111.48M | +3.6% | +2.7% |
| December 31, 2024 | 108.52M | +1.3% | +0.4% |
| September 30, 2024 | 108.10M | +1.3% | +0.1% |
| June 30, 2024 | 108.01M | +1.3% | +0.4% |
| March 31, 2024 | 107.60M | +1.3% | +0.5% |
| December 31, 2023 | 107.08M | +1.9% | +0.3% |
- NovoCure Ltd showed an increase of +3.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2014–2025 period, NovoCure Ltd’s shares outstanding has grown by 737.5% (from 13.43 million shares to 112.49 million shares).
- The most recent figure is from NovoCure Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: